Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease

Yupelri™ is a long-acting muscarinic antagonist indicated for the treatment of chronic obtrusive pulmonary disease in adult patients. Image courtesy of FreeImages.com/Dave Kennard.

  • Yupelri
  • Yupelri
  • Yupelri

Go Top